{"id":"W2943834628","doi":"10.1158/1538-7445.sabcs18-pd2-04","title":"Abstract PD2-04: Baseline circulating <i>ESR1</i> mutation analysis in the randomised phase III EFECT study of fulvestrant versus exemestane in advanced hormone receptor positive breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Exemestane; Fulvestrant; Medicine; Internal medicine; Oncology; Aromatase inhibitor; Breast cancer; Hazard ratio; Metastatic breast cancer; Cancer; Triptorelin; Estrogen receptor; Gynecology; Aromatase; Gastroenterology; Confidence interval; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002865269,0.0002989755,0.0009480474,0.0008662379,0.0001002245,0.00002728085,0.0003108155,0.00009965699,0.0007638615],"category_scores_gemma":[0.0001771084,0.0002301725,0.0001812383,0.003638633,0.000172479,0.0002934718,0.00004787712,0.0009110327,0.000007452088],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001013531,"about_ca_system_score_gemma":0.0005291214,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008365841,"about_ca_topic_score_gemma":0.003451707,"domain_scores_codex":[0.9956833,0.0006800523,0.0008456636,0.0007155524,0.001367898,0.0007075224],"domain_scores_gemma":[0.9969825,0.001313319,0.0002806617,0.0006412708,0.0006456481,0.0001366501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.2537874,0.003079415,0.02447042,0.0003157564,0.001628239,0.0002847532,0.01531359,0.02559972,0.5811372,0.000009960289,0.00002646628,0.0943471],"study_design_scores_gemma":[0.3758089,0.002759374,0.5738543,0.0008885991,0.0007341235,0.00002330619,0.03233597,0.002871389,0.0101096,0.00002538171,0.0000551789,0.0005339303],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921423,0.002471015,0.00007447081,0.0006082692,0.0001216584,0.004194612,0.0002064366,0.00002320423,0.0001580494],"genre_scores_gemma":[0.9980337,0.0004123531,0.00007980078,0.00006219454,0.0001361717,0.001078893,0.00009472291,0.00004790827,0.00005425592],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5710276,"threshold_uncertainty_score":0.9982376,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04074556143826198,"score_gpt":0.4134207069088296,"score_spread":0.3726751454705676,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}